These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32259358)

  • 1. Useful parameters to predict the presence of detrusor overactivity in male patients with lower urinary tract symptoms.
    Matsukawa Y; Majima T; Ishida S; Funahashi Y; Kato M; Gotoh M
    Neurourol Urodyn; 2020 Jun; 39(5):1394-1400. PubMed ID: 32259358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of intravesical prostatic protrusion in the evaluation of overactive bladder in male patients with LUTS.
    Tsai CH; Lee WC; Shen YC; Wang HJ; Chuang YC
    Int Urol Nephrol; 2020 May; 52(5):815-820. PubMed ID: 31897874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we predict detrusor overactivity in women with lower urinary tract symptoms? The King's Detrusor Overactivity Score (KiDOS).
    Giarenis I; Musonda P; Mastoroudes H; Robinson D; Cardozo L
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():127-32. PubMed ID: 27592416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of resistive index of the prostate and bladder sonomorphologic parameters as replacements for urodynamics to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Garg G; Sankhwar SN; Goel A; Pandey S; Sharma D; Parihar A
    Low Urin Tract Symptoms; 2019 May; 11(3):163-168. PubMed ID: 30793849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and useful signs to differentiate detrusor underactivity from bladder outlet obstruction in men with non-neurogenic lower urinary tract symptoms.
    Matsukawa Y; Yoshida M; Yamaguchi O; Takai S; Majima T; Funahashi Y; Yono M; Sekido N; Gotoh M
    Int J Urol; 2020 Jan; 27(1):47-52. PubMed ID: 31542892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical prostatic protrusion can predict therapeutic response to silodosin in male patients with lower urinary tract symptoms.
    Matsukawa Y; Ishida S; Majima T; Funahashi Y; Sassa N; Kato M; Yoshino Y; Gotoh M
    Int J Urol; 2017 Jun; 24(6):454-459. PubMed ID: 28370376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Prostate Symptom Score for assessing lower urinary tract dysfunction in women.
    Hsiao SM; Lin HH; Kuo HC
    Int Urogynecol J; 2013 Feb; 24(2):263-7. PubMed ID: 22588143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction.
    Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y
    Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Suzuki T; Otsuka A; Ozono S
    Int J Urol; 2016 Nov; 23(11):929-933. PubMed ID: 27545297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urodynamic findings in women with refractory overactive bladder symptoms.
    Al-Zahrani AA; Gajewski J
    Int J Urol; 2016 Jan; 23(1):75-9. PubMed ID: 26417863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What are the predicting factors for the therapeutic effects of dutasteride in male patients with lower urinary tract symptoms? Investigation using a urodynamic study.
    Matsukawa Y; Kato M; Funahashi Y; Majima T; Yamamoto T; Gotoh M
    Neurourol Urodyn; 2017 Sep; 36(7):1809-1815. PubMed ID: 28102554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detrusor overactivity and underactivity: implication for lower urinary tract symptoms related to benign prostate hyperplasia diagnosis and treatment.
    Creta M; Collà Ruvolo C; Longo N; Mangiapia F; Arcaniolo D; DE Sio M; DE Nunzio C; Imbimbo C; Mirone V; Fusco F
    Minerva Urol Nephrol; 2021 Feb; 73(1):59-71. PubMed ID: 32026666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of persistent storage symptoms after transurethral resection of the prostate in patients with benign prostatic enlargement.
    Choi H; Kim JH; Shim JS; Park JY; Kang SH; Moon du G; Cheon J; Lee JG; Kim JJ; Bae JH
    Urol Int; 2014; 93(4):425-30. PubMed ID: 25300422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of serum 25-OH vitamin D level on lower urinary tract symptoms in men: a step towards reducing overactive bladder.
    Yoo S; Oh S; Kim HS; Choi HS; Park J; Cho SY; Son H; Jeong H; Lee HW; Cho MC
    BJU Int; 2018 Oct; 122(4):667-672. PubMed ID: 29745000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
    Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of poor urethral sphincter relaxation in men with voiding dysfunction refractory to α-blocker therapy: Clinical characteristics and predictive factors.
    Shao IH; Kuo HC
    Low Urin Tract Symptoms; 2019 Jan; 11(1):8-13. PubMed ID: 28840669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms?
    Cornu JN; Grise P
    Curr Opin Urol; 2016 Jan; 26(1):17-21. PubMed ID: 26574877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of urgency severity is the most important factor in the subjective therapeutic outcome of intravesical onabotulinumtoxinA injection for overactive bladder.
    Jiang YH; Kuo HC
    Neurourol Urodyn; 2017 Feb; 36(2):338-343. PubMed ID: 26575613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective impacts of tadalafil on storage and voiding function in male patients with benign prostatic hyperplasia: 1-year outcomes from a prospective urodynamic study.
    Matsukawa Y; Takai S; Majima T; Funahashi Y; Sassa N; Kato M; Yamamoto T; Gotoh M
    World J Urol; 2019 May; 37(5):867-872. PubMed ID: 30121825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.